The Motley Fool, founded in 1993 by brothers David and Tom Gardner, is a multimedia financial services company dedicated to empowering individual investors with accessible, actionable advice. Headquartered in Alexandria, Virginia, the company offers a range of products, including stock recommendations, investment research, and personal finance guidance, through its popular website, newsletters, podcasts, and premium subscription services.
The Financial Stock Big Money Managers Are Quietly Buying As the popular fintech stock trades sideways, institutional investors are increasing their positions.
The Best Stocks to Buy Right Now for February Chewy and Dutch Bros are two top growth stocks to buy in February.
Could Applied Digital Stock Help You Become a Millionaire? The data center company has signed blockbuster leases that will deliver billions of dollars in revenue.
Disney's New CEO Will Be Great for Investors Disney veteran Josh D'Amaro will take over as CEO in March as investors look for the stock to gain momentum.
This Restaurant-Focused Fintech Has a Recurring-Revenue Machine That Is Getting Hard to Ignore A behind-the-scenes fintech powering everyday restaurant transactions is quietly proving it has the kind of sticky, recurring-revenue engine that long-term investors shouldn't overlook.
Why Aerovironoment Stock Gained 15% in January Aerovironment looks like a winner if military spending ramps up.
Why Woodward Stock Popped Today The industrial equipment maker's investors have larger dividends headed their way.
Overlooked and Undervalued: Why Bausch Health Companies Deserves Attention Bausch Health's turnaround could pay off for value investors patient enough to wait for it.
Lucid Group: Great Cars, Troubling Stock. Is It Still Too Risky to Touch? Lucid makes some impressive cars, but it turns out beating Bugattis down the drag strip is the easy part.
How Duolingo Stock Fell 23.6% in January Duolingo shares hit their lowest price since 2023. Is the sell-off overdone?
Why Figma Stock Lost 31% in January Weakness in the software sector punished Figma.
Why 2026 Could Be the Year Pfizer's Stock Finally Takes Off The company expects to launch more than 20 pivotal late-stage trials this year.
Nvidia Stock Investors Got Great News From Palantir and Teradyne Nvidia reports its quarterly results on Feb. 25, and all signs so far are pointing to a great quarter.
What's Wrong With UnitedHealth Stock? UnitedHealth stock has lost close to half of its value within just the past 12 months.
Up 1,500%, Should You Buy Sandisk Right Now? Not everyone will be able to stomach potential volatility.
3 No-Brainer Ultra-High-Yield Energy Stocks to Buy Right Now Here's how you can collect reliable yields of as much as 6.3% today in the energy sector.
Why Rigetti Stock Fell 18% in January To Start 2026 Rigetti investors have been on quite a ride in recent months.
The Motley Fool Interviews Janus Henderson Investors Portfolio Manager Denny Fish Denny Fish is a portfolio manager for the Janus Henderson Investors Global Technology and Innovation Fund.
Eli Lilly Is Getting Into the Hearing Loss Market in a $1.12 Billion Deal With Seamless Therapeutics While riding high on the popularity of its weight loss drug Zepbound, the company is quietly building a presence in a cutting-edge healthcare segment.
3 Reasons to Buy the Dip on Microsoft Stock Microsoft's recent 10% sell-off offers a great potential stock-buying opportunity.
Does Chipotle Really Deserve Its Premium Valuation Anymore? With management forecasting flat comparable restaurant sales in 2026, the burrito chain stock's recent rebound may be called into question.
Is Amphenol Stock the Next Big Opportunity? Here's What You Need to Know. Could Amphenol be the next big winner in the tech sector? Join us as we explore its strengths, management, and financials to see if this stock is worth your investment.
Stock Market Today, Feb. 3: Novo Nordisk Slides as Pricing Pressure Clouds Obesity-Drug Outlook Novo Nordisk dropped after management forecasts weaker 2026 growth, shifting attention from recent results to pricing pressure and rising competition in obesity treatments.
The Smartest Growth Stock to Buy With $30 Right Now This pre-revenue biopharmaceutical stock is a home run swing worth taking.
Stock Market Today, Feb. 3: Rocket Companies Rallies on Signs of Mortgage Demand Recovery Rocket Companies advanced after its CEO said mortgage loan production has reached a four-year high, as the market revisits the outlook for housing demand.
Is e.l.f. Beauty Stock a Hidden Gem in the Cosmetics Aisle? E.l.f. Beauty is growing its top line rapidly by attracting cost-conscious consumers.
Stock Market Today, Feb. 3: PayPal Plunges After Earnings Miss and Weak 2026 Profit Outlook Today, Feb. 3, 2026, investors are weighing a rare earnings stumble against fresh leadership, buybacks, and a balance-sheet reset.
Lumbard Kellner Loads Up UiPath With 224,000 Shares Bought UiPath delivers automation software and AI-driven solutions to enterprise clients across banking, healthcare, and government sectors.
Stock Market Today, Feb. 3: Palantir Technologies Surges After Record Revenue Growth and Strong AI Demand Record revenue, accelerating AI demand, and bullish analyst upgrades put this data analytics leader in sharp focus, today, Feb. 3, 2026.
How Much Dividend Income Can You Get From $250,000? Usually in the ballpark of a few thousand bucks per year, but the precise answer ultimately depends on what your goal is, and what you're willing to give up.
2 Healthcare Dividend Stocks That are Just What the Doctor Ordered AbbVie and Medtronic have a long history of raising their dividends and continue to have healthy free cash flow for further dividend growth.
Netflix Stock Dips Below $80. Time to Buy? The streaming service company's stock has fallen 40% from highs last summer.
Stock Market Today, Feb. 3: Nasdaq Tumbles 1.4% as AI Fears Grow Today, Feb. 3, 2026, Walmart’s $1 trillion milestone stands out as rising bond yields and tech weakness drag major U.S. indexes lower.
